Početna › Rak (sve vrste) › Minnesota
Kliničke studije za Rak (sve vrste) u državi Minnesota
50 studija za Rak (sve vrste) traži sudionike na lokacijama u državi Minnesota.
Gradovi u državi Minnesota
Službeni tekst studije (engleski)
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
- University Of Minnesota /ID# 277850, Minneapolis
U tijeku regrutacijaFaza 2
Od 18 godina i više · Žene · Ažurirano 1. lis 2026. · NCT07024784A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- HealthPartners Cancer Research Center /ID# 277339, Saint Louis Park
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07155187A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
- Investigative Site, Rochester
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT06881992Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Mayo Clinic Rochester, Rochester
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT04981119A Study of JNJ-1761981 in Participants With Solid Tumors
- Mayo Clinic Rochester, Rochester
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07525141A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester
- Mayo Clinic, Rochester
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06989437A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- Metro Minnesota Community Oncology Research Consortium (MMCORC), Saint Louis Park
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT06901531A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Minnesota Oncology - Edina Clinic /ID# 280698, Edina
- Mayo Clinic Hospital Rochester /ID# 279784, Rochester
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT07365241Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- M Health Fairview University of Minnesota Medical Center - East Bank, Minneapolis
- Mayo Clinic, Rochester
U tijeku regrutacijaFaza 2/3
Sve dobne skupine · Oba spola · Ažurirano 18. ruj 2026. · NCT03435796Connect for Cancer Prevention Study (Connect)
- HealthPartners, Minneapolis
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 30 do 70 godina · Oba spola · Ažurirano 17. ruj 2026. · NCT04609072Statins to Prevent Cancer Associated Blood Clots
- Mayo Clinic, Rochester
U tijeku regrutacijaFaza 4
Od 18 godina i više · Oba spola · Ažurirano 16. ruj 2026. · NCT07303816Biomarkers of Resiliency In Childhood Cancer Surgery
- Mayo Clinic, Rochester
U tijeku regrutacijaOpažajna studija
Od 3 do 25 godina · Oba spola · Ažurirano 14. ruj 2026. · NCT06674811A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
- Mayo Clinic Rochester, Rochester
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 11. ruj 2026. · NCT06634589A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
- HealthPartners Cancer Research Center, Saint Paul
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT06119581A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
- Mayo Clinic Rochester, Rochester
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 3. ruj 2026. · NCT06163534Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Mayo Clinic-Comprehensive Cancer Center-Breast Clinic, Rochester
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 2. ruj 2026. · NCT06072612Project: Every Child for Younger Patients With Cancer
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
- Mayo Clinic in Rochester, Rochester
U tijeku regrutacijaOpažajna studija
Do 25 godina · Oba spola · Ažurirano 25. kol 2026. · NCT02402244Abatacept in Immune Checkpoint Inhibitor Myocarditis
- Mayo Clinic, Rochester
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 20. kol 2026. · NCT05335928FOG-001 in Locally Advanced or Metastatic Solid Tumors
- M Health Fairview University of Minnesota Medical Center, Minneapolis
- Mayo Clinic, Rochester
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 17. kol 2026. · NCT05919264A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
- University of Minnesota Hospital, Minneapolis
U tijeku regrutacijaFaza 2
Od 1 do 39 godina · Oba spola · Ažurirano 7. kol 2026. · NCT05999994Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Riverwood Healthcare Center, Aitkin
- Essentia Health - Baxter Clinic, Baxter
- Sanford Joe Lueken Cancer Center, Bemidji
- i još 48
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 7. kol 2026. · NCT06580314A Study of ASP1002 in Adults for Treatment of Solid Tumors
- HealthPartners Cancer Research Center, Saint Paul
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 23. srp 2026. · NCT05719558Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- 518, Minneapolis
U tijeku regrutacijaFaza 2
Od 18 godina i više · Žene · Ažurirano 16. srp 2026. · NCT06906341Capturing Food Intake in Patients Undergoing Radiation Therapy for Cancer
- University Of Minnesota, Minneapolis
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 14. srp 2026. · NCT07682714A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Mayo Clinic - Rochester /ID# 251164, Rochester
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 13. srp 2026. · NCT05650632A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- Scri Minnesota Oncology Hematology, P.A. /ID# 275149, Minneapolis
- Mayo Clinic-Rochester /ID# 273508, Rochester
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 10. srp 2026. · NCT07023289Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
- Allina Health, Virginia Piper Cancer Institute, Coon Rapids
- Virginia Piper Cancer Institute Mercy Hospital-Unity Campus, Fridley
- VPCI Oncology Research, Minneapolis
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 10. srp 2026. · NCT05181826A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- Mayo Clinic, Rochester
U tijeku regrutacijaFaza 1
Od 18 godina i više · Muškarci · Ažurirano 9. srp 2026. · NCT07103018A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
- GSK Investigational Site, Minneapolis
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 25. lip 2026. · NCT06431594Childhood Cancer Survivor Study
- Children's Hospitals & Clinics of Minnesota, Minneapolis
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Sve dobne skupine · Oba spola · Ažurirano 17. lip 2026. · NCT01120353A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- Mayo Clinic Rochester, Rochester
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 12. lip 2026. · NCT06051695Patient Derived Preclinical Models
- Mayo Clinic in Rochester, Rochester
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 9. lip 2026. · NCT05324553Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Children's Hospital and Clinics of Minn, Minneapolis
U tijeku regrutacijaFaza 1/2
12 Months – 30 Years · Oba spola · Ažurirano 19. svi 2026. · NCT04901702The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
- Mayo Clinic, Rochester
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 15. svi 2026. · NCT07224464A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
- Mayo Clinic Rochester, Rochester
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 8. svi 2026. · NCT05954312I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
- University of Minnesota, Minneapolis
- Mayo Clinic, Rochester
- Metro Minnesota Community Oncology Research Consortium, Hennepin County Medical Center, Saint Louis Park
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 6. svi 2026. · NCT01042379Axelopran for Advanced Cancer in Patients Receiving Opioids
- HealthPartners Frauenshuh Cancer Research Center, Saint Louis Park
- HealthPartners Cancer Center at Regions Hospital, Saint Paul
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 5. svi 2026. · NCT07354919CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Mayo Clinic, Rochester
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 16. tra 2026. · NCT03328078INTERogating Cancer for Etiology, Prevention and Therapy Navigation
- Mayo Clinic in Rochester, Rochester
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 7. tra 2026. · NCT06008392Multi-Cancer Detection Observational Cohort Study
- Mayo Clinic in Rochester, Rochester
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 21 godina i više · Oba spola · Ažurirano 6. tra 2026. · NCT06962995Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.